PT2330131E - Anticorpos contra a variante truncada de her-2 ctf-611 - Google Patents
Anticorpos contra a variante truncada de her-2 ctf-611 Download PDFInfo
- Publication number
- PT2330131E PT2330131E PT93801835T PT09380183T PT2330131E PT 2330131 E PT2330131 E PT 2330131E PT 93801835 T PT93801835 T PT 93801835T PT 09380183 T PT09380183 T PT 09380183T PT 2330131 E PT2330131 E PT 2330131E
- Authority
- PT
- Portugal
- Prior art keywords
- ctf
- her2
- antibody
- fragment
- seq
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09380183.5A EP2330131B1 (de) | 2009-12-07 | 2009-12-07 | Antikörper gegen die HER2-verkürzte Variante CTF-611 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2330131E true PT2330131E (pt) | 2015-01-14 |
Family
ID=42077878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT93801835T PT2330131E (pt) | 2009-12-07 | 2009-12-07 | Anticorpos contra a variante truncada de her-2 ctf-611 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8741586B2 (de) |
| EP (3) | EP2330131B1 (de) |
| JP (1) | JP5852306B2 (de) |
| CY (1) | CY1115927T1 (de) |
| DK (1) | DK2330131T3 (de) |
| ES (2) | ES2527143T3 (de) |
| HR (1) | HRP20141257T1 (de) |
| PL (1) | PL2330131T3 (de) |
| PT (1) | PT2330131E (de) |
| SI (1) | SI2330131T1 (de) |
| SM (1) | SMT201500001B (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2235536A4 (de) | 2007-12-20 | 2011-05-04 | Lab Corp America Holdings | Her-2-diagnoseverfahren |
| CA2764386C (en) | 2008-12-01 | 2018-05-01 | Laboratory Corporation Of America Holdings | P95-her2 antibodies and uses thereof |
| WO2010132723A1 (en) * | 2009-05-14 | 2010-11-18 | Prometheus Laboratories Inc. | Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy |
| US20150010545A1 (en) | 2011-12-27 | 2015-01-08 | Kadmon Corporation, Llc | Methods for treatment of breast cancer nonresponsive to trastuzumab |
| RU2016129517A (ru) * | 2013-12-20 | 2018-01-25 | Ф. Хоффманн-Ля Рош Аг | Биспецифические антитела к her2 и способы применения |
| MA44334A (fr) | 2015-10-29 | 2018-09-05 | Novartis Ag | Conjugués d'anticorps comprenant un agoniste du récepteur de type toll |
| JP7022123B2 (ja) | 2016-09-30 | 2022-02-17 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | Ｃｄ３に対する二重特異性抗体 |
| JPWO2018116465A1 (ja) * | 2016-12-22 | 2019-10-24 | 日立化成株式会社 | Ｈｅｒ２陽性癌細胞の検出方法 |
| AR111651A1 (es) | 2017-04-28 | 2019-08-07 | Novartis Ag | Conjugados de anticuerpos que comprenden agonistas del receptor de tipo toll y terapias de combinación |
| US20210346484A1 (en) * | 2017-12-11 | 2021-11-11 | Medizinische Universitaet Wien | Method of producing a vaccine composition and uses thereof |
| CN110865184B (zh) * | 2019-12-04 | 2023-04-07 | 广州医科大学附属第三医院（广州重症孕产妇救治中心、广州柔济医院） | Srsp蛋白和srsp抗原表位肽的应用及诊断和治疗肿瘤的产品 |
| EP3915576A1 (de) | 2020-05-28 | 2021-12-01 | Fundació Privada Institut d'Investigació Oncològica de Vall-Hebron | Für p95her2 spezifische chimäre antigenrezeptoren und deren verwendung |
| AU2021387127A1 (en) * | 2020-11-30 | 2023-06-22 | Ono Pharmaceutical Co., Ltd. | Her2 targeting agent |
| WO2023143322A1 (zh) * | 2022-01-26 | 2023-08-03 | 山东先声生物制药有限公司 | p95HER2抗体及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3040121B2 (ja) | 1988-01-12 | 2000-05-08 | ジェネンテク，インコーポレイテッド | 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法 |
| ES2342646B1 (es) * | 2008-06-02 | 2011-04-26 | Institut De Recerca Hospital Universitari Vall Hebron | Metodo de diagnostico de canceres que expresan el receptor her-2 o sus variantes truncadas. |
| CA2764386C (en) * | 2008-12-01 | 2018-05-01 | Laboratory Corporation Of America Holdings | P95-her2 antibodies and uses thereof |
-
2009
- 2009-12-07 ES ES09380183.5T patent/ES2527143T3/es active Active
- 2009-12-07 SI SI200931099T patent/SI2330131T1/sl unknown
- 2009-12-07 DK DK09380183.5T patent/DK2330131T3/da active
- 2009-12-07 PL PL09380183T patent/PL2330131T3/pl unknown
- 2009-12-07 PT PT93801835T patent/PT2330131E/pt unknown
- 2009-12-07 EP EP09380183.5A patent/EP2330131B1/de active Active
-
2010
- 2010-12-06 US US12/961,004 patent/US8741586B2/en active Active
- 2010-12-07 ES ES10193969.2T patent/ES2581627T3/es active Active
- 2010-12-07 JP JP2010272944A patent/JP5852306B2/ja not_active Expired - Fee Related
- 2010-12-07 EP EP10193969.2A patent/EP2360187B1/de not_active Not-in-force
- 2010-12-07 EP EP15195339.5A patent/EP3048117A1/de not_active Withdrawn
-
2014
- 2014-12-17 CY CY20141101055T patent/CY1115927T1/el unknown
- 2014-12-23 HR HRP20141257AT patent/HRP20141257T1/hr unknown
-
2015
- 2015-01-02 SM SM201500001T patent/SMT201500001B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP5852306B2 (ja) | 2016-02-03 |
| CY1115927T1 (el) | 2017-01-25 |
| US20110135653A1 (en) | 2011-06-09 |
| EP3048117A1 (de) | 2016-07-27 |
| EP2360187B1 (de) | 2016-04-20 |
| EP2360187A1 (de) | 2011-08-24 |
| SMT201500001B (it) | 2015-03-05 |
| ES2527143T3 (es) | 2015-01-20 |
| EP2330131B1 (de) | 2014-10-08 |
| DK2330131T3 (da) | 2015-01-05 |
| US8741586B2 (en) | 2014-06-03 |
| JP2011121943A (ja) | 2011-06-23 |
| HRP20141257T1 (en) | 2015-03-13 |
| PL2330131T3 (pl) | 2015-05-29 |
| SI2330131T1 (sl) | 2015-02-27 |
| EP2330131A1 (de) | 2011-06-08 |
| ES2581627T3 (es) | 2016-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5753079B2 (ja) | Ｈｅｒ２受容体またはその末端切断変異体を発現する癌を診断するための方法 | |
| PT2330131E (pt) | Anticorpos contra a variante truncada de her-2 ctf-611 | |
| JP5271443B2 (ja) | 可溶型の炭酸脱水酵素ＩＸ（ｓ−ＣＡＩＸ）、ｓ−ＣＡＩＸを検出するためのアッセイ、ＣＡＩＸとＨＥＲ−２／ｎｅｕ／ｃ−ｅｒｂＢ−２の同時発現、非免疫優性エピトープに対するＣＡＩＸ特異的モノクローナル抗体 | |
| KR102550489B1 (ko) | 암 진단에 유용한 항체 | |
| US8821872B2 (en) | Identification and characterization of a specific CCK-C receptor antibody for human pancreatic cancer and its use for early detection and staging of pancreatic cancer | |
| JP6187960B2 (ja) | がんの治療又は予防剤 | |
| KR101951775B1 (ko) | Mel-18 단백질의 인산화 검출용 항체 및 이의 용도 | |
| JP2010241783A (ja) | 抗ａｔｂｆ１抗体及びその用途 | |
| JPWO2018034332A1 (ja) | ＥｐｈＡ２ Ｎ末端フラグメント抗体 |